Publications by authors named "K Kai"

Dasatinib, a second-generation tyrosine kinase inhibitor, has been reported to have immunomodulatory effects. Epstein-Barr virus (EBV)-associated lymphoproliferative disorders (EBV-LPD) occur in immunocompromised patients, such as those receiving methotrexate or other immunosuppressive drugs or after allogenic transplantation. EBV-LPD is also reported to be a rare side effect in patients receiving long-term dasatinib or imatinib.

View Article and Find Full Text PDF

Dendritic cells (DCs) are known to be major antigen-presenting cells, and lymph nodes (LNs) play an important role in DC-mediated immune response. CD1a is known as a marker of monocyte-derived DCs. The present study focused on the infiltration of CD1a-positive DCs (CD1a-DCs) into regional LNs in 70 cases of gallbladder cancer (GBC).

View Article and Find Full Text PDF

Metabolic dysfunction-associated steatotic liver disease (MASLD) is becoming a major health problem worldwide. Liver regeneration is crucial for restoring liver function, and is regulated by extraordinary complex process, involving numerous factors under both physiologic and pathologic conditions. Sphingosine-1-phosphate (S1P), a bioactive sphingolipid synthesized by sphingosine kinase 1 (SphK1), plays an important role in liver function through S1P receptors (S1PRs)-expressing cells.

View Article and Find Full Text PDF
Article Synopsis
  • - Glioblastoma (GBM) is a highly aggressive brain tumor with no effective treatments, and its tumor microenvironment is characterized as immunosuppressive, containing many glioma-associated macrophages/microglia (GAMs) that aid tumor growth and treatment resistance.
  • - The review discusses the classification and origin of GAMs, their activation mechanisms, interactions with tumor cells, and the historical and modern techniques for detecting GAMs, particularly immunohistochemistry.
  • - Recent advancements like single-cell RNA analysis provide new insights into GAMs, suggesting that therapies targeting these cells may be key to improving treatment options for GBM in the future.
View Article and Find Full Text PDF

Endometrioid adenocarcinoma of the uterine cervix is rare and difficult to distinguish from endometrial adenocarcinoma, particularly in large bulky cases. Herein, we report a rare case of a large endometrioid adenocarcinoma in a 58-year-old Japanese woman in which the tumor origin was difficult to identify. The patient presented with abdominal pain and vaginal bleeding and was referred to a gynecologist for suspected uterine cancer based on an evaluation performed at another institution.

View Article and Find Full Text PDF